+428.5%
MRNA vs SOLS
+17.0%
+411.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SOLS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | 0.0% | +5.4% | +5.4% |
| 7D | -1.1% | -3.5% | +2.4% | -1.6% |
| 30D | +126.1% | -1.0% | +127.1% | +129.8% |
| 3M | +190.0% | -24.1% | +214.1% | +202.0% |
| 6M | +157.2% | -18.0% | +175.2% | +161.8% |
| YTD | +388.2% | +27.1% | +361.1% | +338.3% |
| All | +428.5% | +17.0% | +411.5% | +373.6% |
Cumulative growth
Daily Returns
Daily percentage return beside SOLS.
Daily Out/Under-Performance
Portfolio return minus SOLS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SOLS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SOLS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling